Concepedia

Christoph Dahlhoff

CD

4

Publications

119

Citations

4

H-Index

2007

Active since

Affiliations

Amgen (United States)(Current)

Amgen (Germany)

Christoph Dahlhoff is an author at Amgen (United States) specializing in medicine, cellular physiology, and allergy.

Top concepts

Publications per year

2007–2021

4

Publications

4

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

Bettina Brauchle, Rebecca Goldstein, Christine M. Karbowski et al. · Molecular Cancer Therapeutics · 2020 · 50 citations · Full text

Upregulated expression of ENaC in human CF nasal epithelium

Nadine Bangel, Christoph Dahlhoff, Katja Sobczak et al. · Journal of Cystic Fibrosis · 2007 · 35 citations

, , +2

Generation of a Half-Life Extended Anti-CD19 BiTE® Antibody Construct Compatible with Once-Weekly Dosing for Treatment of CD19-Positive Malignancies

Grit Lorenczewski, Matthias Friedrich, Roman Kischel et al. · Blood · 2017 · 24 citations

Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule

Elizabeth Pham, Matthias G. Friedrich, Famke Aeffner et al. · Molecular Cancer Therapeutics · 2021 · 10 citations · Full text

Rows per page

1–4 of 4